SA0007879188
SA0007879188
Saudi Pharmaceutical Industries
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.706.711.000 | 1.682.000.000 | 1.5% |
| Cost of Revenue | 874.157.000 | 844.970.000 | 3.5% |
| Gross Profit | 832.554.000 | 837.030.000 | 0.5% |
| 584.680.000 | 679.321.000 | 13.9% | |
| Operating Income | 247.874.000 | 157.709.000 | 57.2% |
| Pretax Income | 205.650.000 | 72.009.000 | 185.6% |
| Net Income Common Stockholders | 184.363.000 | 24.535.000 | 651.4% |
| -- | -- | -- | |
| -- | -- | -- |